August 18, 2020
Juul Labs today announced that it received notice from the Food and Drug Administration (FDA) that the company’s Premarket Tobacco Product Applications (PMTA) will enter the substantive review phase.
July 30, 2020
The company’s submission includes comprehensive scientific evidence for the JUUL Device and JUULpods in Virginia Tobacco and Menthol flavors at nicotine concentrations of 5.0% and 3.0%, as well as information on its data-driven measures to address underage use of its products.
August 20, 2019
We are fully committed to the current PMTA process and are confident in the content and quality of the materials we will submit with our application by…